A Phase III, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection

Brief Summary

Type:
Prostate

Study Type:
Diagnostic

Phase:
III

ClinicalTrials.gov Identifier:
NCT06235151

Study #:
STUDY00160366

Start Date:
Jul 17, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06235151

View Complete Trial Details & Eligibility at ClinicalTrials.gov